Karlin Dan's Form 4 filing
Definium Therapeutics, Inc. (DFTX) · filed May 31, 2022
- Accession no.
- 0001209191-22-032973
- Filed
- May 31, 2022
- Trade date
- May 27, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $7.84K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Karlin DanCIK 0001897618 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 27, 2022 | Subordinate Voting Shares | SSaleDisposed | −9,555 | $0.82F2 | −$7,835.1 | 4,077,719 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The Subordinate Voting Shares were sold in one transaction at a price of $1.05 CAD dollars to cover payroll taxes. This represents the price in U.S. Dollars using the conversion rate on May 27, 2022.
Referenced by the price of 1 transaction in Table I.